Chimera Investment Corp (CIM.PB) stock analysis

CIM.PBNYSEReal Estate Investment TrustsFiscal year ends December 31Also trades as CIM, CIM.PA, CIM.PC, CIM.PD, CIMN, CIMO, CIMP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3036% below fair value

$21.16+0.01 (+0.07%)

Close on Oct 30, 2026Market cap $694.81MP/E –Yield 17.83%

StockData Score

Prices as of Oct 30, 2026How the score works

Mixed11 of 30 checks passed

Chimera Investment passes 11 of the 30 checks behind our score; 13 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation: 3/6
Growth: 0/6
Past performance: 1/6
Financial health: 4/6
Dividend: 3/6

What stands out

Margin of safety over 20%
The price is 36.5% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $8.30 is below our fair value estimate of $13.06.
No debt
Chimera Investment has no borrowings on its latest balance sheet.
Earnings grew over 5 years
Net income grew 21.0% a year on average over the last five fiscal years.

What to watch

Return on equity under 15%
Return on equity was 0.0% over the last twelve months and averaged 4.5% over five years; we look for 15% on both.
Earnings growth not accelerating
Net income grew -99.4% over the last twelve months, against a 5-year average of 21.0% a year.
Elevated bankruptcy risk
The Altman Z-score is 0.43; above 3 is the safe zone and below 1.8 the distress zone.
Not covered by earnings
Dividends take 10894% of net income, leaving little room.

Valuation3/6

P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B below the industry
Chimera Investment's price-to-book of 0.29 is below the Miscellaneous Investing median of 1.20.
Trading below fair value
The share price of $8.30 is below our fair value estimate of $13.06.
Margin of safety over 20%
The price is 36.5% below fair value, more than the 20% cushion we look for.

Growth0/6

Revenue growth over 3 years
Needs three years of positive revenue.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth not accelerating
Net income grew -99.4% over the last twelve months, against a 5-year average of 21.0% a year.
Growth against the industry
Needs revenue for this year and last.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
This company does not report gross profit.

Past performance1/6

Return on equity under 15%
Return on equity was 0.0% over the last twelve months and averaged 4.5% over five years; we look for 15% on both.
Return on invested capital
Needs operating income and invested capital.
Return on equity below the industry
Chimera Investment's return on equity of 0.0% is below the Miscellaneous Investing median of 3.4%.
Earnings grew over 5 years
Net income grew 21.0% a year on average over the last five fiscal years.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.

Financial health4/6

No debt
Chimera Investment has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Elevated bankruptcy risk
The Altman Z-score is 0.43; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6

Pays a dividend
Chimera Investment paid dividends worth 20.7% of the share price over the last twelve months.
Yield above Treasuries
The 20.7% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 4.0% or more; Chimera Investment yields 20.7%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Not covered by earnings
Dividends take 10894% of net income, leaving little room.
Cash-flow cover
Needs dividends paid and free cash flow.

Scores of similar companies

Fair value

How we estimate it

Our estimate per share

$13.06

The share price is 36% below this estimate.

20%+ below

Near fair value

20%+ above

$8.30Price$13.06Fair value

Method	Multiple used	Own 5Y median	Industry median	Value per share	Weight
P/B	0.8×	0.4×	1.2×	$23.71	40%
Earnings power	11.4% cost of equity	–	–	$5.96	60%
Fair value				$13.06	100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

P/E at month end
Own 5-year median 9.3
Miscellaneous Investing median 25.0

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day: $14.20M
Value traded per 1% price move: $10.19M

Downside

Medium risk

Typical loss in a bad month: 22.4%
Volatility (annualized): 27%
Sharpe ratio, 1 year: -1.44
Beta to the S&P 500 (5Y): 1.28

Typical bad-month loss, week by week

Margins need revenue and profit figures

This company does not report the lines needed to calculate margins.

Growth rates

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Net income	+30.9%	–	+21.0%	-0.8%
EPS, diluted	+56.4%	–	+52.3%	-7.5%
Dividend per share	+4.2%	+29.0%	-18.8%	-12.7%

Measure	FY2016	FY2020	FY2025
Return on equity	18.2%	2.3%	9.0%
Return on assets	3.4%	0.4%	1.6%
Diluted shares	63M	75M	84M